Healthy aging starts in the gut
Plant actives that restart the aging gut.
Plant actives for food, supplement and nutrition brands. First product ships in 2027.
Your gut holds hundreds of kinds of bacteria. Probiotics deliver a handful of species. The ones that matter most for healthy aging are not among them.
The gut makes the signals that keep us young.
We switch them back on.
-
01
Brain
Guards the blood–brain barrier and calms the brain's immune cells.
-
02
Metabolism and women's health
Sets how the body handles sugar and insulin. Recycles estrogen and sets its level after menopause.
-
03
Immunity and aging
Its fatty acids stop immune cells turning senescent. In mice, a young gut community rejuvenated aged blood stem cells (Zeng 2023, Blood).
The bacteria most closely linked to healthy aging cannot be put in a pill. They are already in you.
Three products, one engine.
Designed to support gut barrier integrity and a healthy inflammatory response, with healthy blood fats and post-meal glucose.
CapsulesDrinksPowders Details Next TRI-01 Gut–brain precision activeDesigned to support memory, mental performance and mood in healthy adults.
≤200 mg a day CapsulesDrinksShotsPowders Details In development TRI-05 Plant-polyphenol bioactiveFor metabolic resilience.
DetailsAll three are made from upcycled agricultural side-streams.
Teroka finds them. And the next ones.
Teroka couples a wetlab that measures how whole human gut communities respond, species by species, with models that learn from every run. It found TRI-01 and TRI-04. Women's health is next from the same engine.
Every run adds to a dataset nobody else has: how the gut's species and metabolic networks respond to plant actives, alone and in combination.
The evidence, step by step.
TRI-01 raised the short-chain fatty acids that gut bacteria make, in gut samples from all six people tested.
- Butyrate +140% Fuels the cells of the gut lining and calms the low-grade inflammation of aging.
- Propionate +90% A signal for blood sugar and metabolic health.
- Acetate +150% Feeds the gut's other good bacteria.
The bacteria that make these acids rose too: our lead species, Agathobaculum butyriciproducens, 45-fold on average, the lowest 12-fold.
Total short-chain fatty acids +120%. Whiskers: ±1 standard error across the six people. Lab (ex-vivo) result on real human guts. Controlled human studies are next.
- Lab result on human gut samples Gut samples from ten people in two labs, every one responded
- Industrial pilot run With Bühler, August 2026
- US GRAS route confirmed feasible October 2026
- Controlled human studies Next: this round takes us there
Ex-vivo (lab) result on gut samples from six people. Controlled human studies are next. See the evidence →
Two founders, 18+ years each.
MIT and Uni Basel; metabolic diseases at Sanofi; CSO InSphero; COO Rejuveron.
B2B partnerships at dsm-firmenich and J&J; deep APAC reach. Max Planck and Cambridge trained.
They advise as individuals; their former employers are not partners or endorsers.









- MassChallenge 2026 Winner
- EIT Food “Food as Medicine”, 1st place 2025
- ARDD 2025, 2nd place
- Probiota Pioneer 2025
From our founders.
What the newest science on the gut, the brain and aging means, written by the people building on it.
Stay close to the science.
Occasional updates on the platform, the evidence, and the category — for formulators, partners, and investors.